Jundishapur Journal of Microbiology

Published by: Kowsar

Correlation Between Mucosal IL-6 mRNA Expression Level and Virulence Factors of Helicobacter pylori in Iranian Adult Patients With Chronic Gastritis

Fatemeh Azadegan-Dehkordi 1 , Nader Bagheri 2 , Mahsa Shirzad 3 , Mohammad Hossein Sanei 4 , Morteza Hashemzadeh-Chaleshtori 1 , Mahmoud Rafieian-Kopaei 3 , Mohammad Amin Tabatabaiefar 5 and Hedayatollah Shirzad 1 , *
Authors Information
1 Cellular and Molecular Research Center, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
2 Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
3 Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
4 Department of Pathology, Isfahan University of Medical Sciences, Isfahan, IR Iran
5 Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan,IR Iran
Article information
  • Jundishapur Journal of Microbiology: August 01, 2015, 8 (8); e21701
  • Published Online: August 29, 2015
  • Article Type: Research Article
  • Received: July 21, 2014
  • Revised: September 18, 2014
  • Accepted: September 30, 2014
  • DOI: 10.5812/jjm.21701

To Cite: Azadegan-Dehkordi F, Bagheri N, Shirzad M, Sanei M H, Hashemzadeh-Chaleshtori M, et al. Correlation Between Mucosal IL-6 mRNA Expression Level and Virulence Factors of Helicobacter pylori in Iranian Adult Patients With Chronic Gastritis, Jundishapur J Microbiol. 2015 ; 8(8):e21701. doi: 10.5812/jjm.21701.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Razavi A, Bagheri N, Azadegan-Dehkordi F, Shirzad M, Rahimian G, Rafieian-Kopaei M. Comparative Immune Response in Children and Adults with H. pylori Infection. J Immunol Res. 2015; : 315957
  • 2. Shirzad H, Bagheri N, Azadegan-Dehkordi F, Zamanzad B, Izadpanah E, Abdi M. New insight to IL-23/IL-17 axis in Iranian infected adult patients with gastritis: effects of genes polymorphisms on expression of cytokines. Acta Gastroenterol Belg. 2015; 78(2): 212-8
  • 3. Bagheri N, Taghikhani A, Rahimian G, Salimzadeh L, Azadegan Dehkordi F, Zandi F, et al. Association between virulence factors of helicobacter pylori and gastric mucosal interleukin-18 mRNA expression in dyspeptic patients. Microb Pathog. 2013; 65: 7-13[DOI][PubMed]
  • 4. Bagheri N, Rahimian G, Salimzadeh L, Azadegan F, Rafieian-Kopaei M, Taghikhani A, et al. Association of the virulence factors of Helicobacter pylori and gastric mucosal interleukin-17/23 mRNA expression in dyspeptic patients. EXCLI J. 2013; 12: 5-14
  • 5. Bagheri N, Azadegan-Dehkordi F, Shirzad M, Zamanzad B, Rahimian G, Taghikhani A. Mucosal interleukin-21 mRNA expression level is high in patients with Helicobacter pylori and is associated with the severity of gastritis. Centr Eur Immunol. 2015; 40(1): 61-7
  • 6. Bagheri N, Azadegan-Dehkordi F, Shirzad H, Rafieian-Kopaei M, Rahimian G, Razavi A. The biological functions of IL-17 in different clinical expressions of Helicobacter pylori-infection . Microb Pathogenesis. 2015; 81: 33-8
  • 7. Zandi F, Shirzad H, Bagheri N, Ahmadi A, Azadegan F, Gharib A, et al. Evaluation of IL-17A and IL-17F genes polymorphism in Iranian dyspeptic patients. Life Sci J. 2013; 10(12s): 544-51
  • 8. Rahimian G, Sanei MH, Shirzad H, Azadegan-Dehkordi F, Taghikhani A, Salimzadeh L, et al. Virulence factors of Helicobacter pylori vacA increase markedly gastric mucosal TGF-beta1 mRNA expression in gastritis patients. Microb Pathog. 2014; 67-68: 1-7[DOI][PubMed]
  • 9. Bagheri N, Azadegan-Dehkordi F, Sanei H, Taghikhani A, Rahimian G, Salimzadeh L, et al. Associations of a TLR4 single-nucleotide polymorphism with H. pylori associated gastric diseases in Iranian patients. Clin Res Hepatol Gastroenterol. 2014; 38(3): 366-71[DOI][PubMed]
  • 10. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52(24): 6735-40[PubMed]
  • 11. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004; 113(3): 321-33[DOI][PubMed]
  • 12. Basso D, Plebani M. H. pylori infection: bacterial virulence factors and cytokine gene polymorphisms as determinants of infection outcome. Crit Rev Clin Lab Sci. 2004; 41(3): 313-37[DOI][PubMed]
  • 13. Salimzadeh L, Bagheri N, Zamanzad B, Azadegan-Dehkordi F, Rahimian G, Hashemzadeh-Chaleshtori M. Frequency of virulence factors in Helicobacter pylori-infected patients with gastritis. Microb Pathogenesis. 2015; 80: 67-72
  • 14. Yamaoka Y, Souchek J, Odenbreit S, Haas R, Arnqvist A, Boren T, et al. Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol. 2002; 40(6): 2244-6[PubMed]
  • 15. Said Essa A, Alaa Eldeen Nouh M, Mohammed Ghaniam N, Graham DY, Said Sabry H. Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt. Scand J Infect Dis. 2008; 40(9): 730-3[DOI][PubMed]
  • 16. Atherton JC, Cao P, Peek RJ, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995; 270(30): 17771-7[PubMed]
  • 17. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter. 1998; 3(4): 241-53[PubMed]
  • 18. Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, et al. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut. 1998; 42(3): 338-43[PubMed]
  • 19. Basso D, Scrigner M, Toma A, Navaglia F, Di Mario F, Rugge M, et al. Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res. 1996; 26(3): 207-10[PubMed]
  • 20. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090): 235-8[DOI][PubMed]
  • 21. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol. 2006; 18(3): 349-56[DOI][PubMed]
  • 22. Zhang XG, Klein B, Bataille R. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood. 1989; 74(1): 11-3[PubMed]
  • 23. Manxhuka-Kerliu S, Telaku S, Devolli-Disha E, Ahmetaj H, Sahatciu-Meka V, Kerliu A, et al. Helicobacter pylori gastritis updated Sydney classification applied in our material. Prilozi. 2009; 30(1): 45-60[PubMed]
  • 24. Liang H, Hussey SE, Sanchez-Avila A, Tantiwong P, Musi N. Effect of lipopolysaccharide on inflammation and insulin action in human muscle. PLoS One. 2013; 8(5)[DOI][PubMed]
  • 25. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter. 2001; 6(2): 116-24[PubMed]
  • 26. Pyo CW, Hur SS, Kim YK, Choi HB, Hong YS, Kim DW, et al. Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10, and IFN-gamma genes in the Korean population. Hum Immunol. 2003; 64(10): 979-89[PubMed]
  • 27. Gionchetti P, Vaira D, Campieri M, Holton J, Menegatti M, Belluzzi A, et al. Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am J Gastroenterol. 1994; 89(6): 883-7[PubMed]
  • 28. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology. 1996; 110(6): 1744-52[PubMed]
  • 29. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut. 1991; 32(12): 1473-7[PubMed]
  • 30. Ashizawa T, Okada R, Suzuki Y, Takagi M, Yamazaki T, Sumi T, et al. Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric Cancer. 2005; 8(2): 124-31[DOI][PubMed]
  • 31. Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y. Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell. 2005; 16(10): 4954-66[DOI][PubMed]
  • 32. Odenbreit S, Linder S, Gebert-Vogl B, Rieder G, Moran AP, Haas R. Interleukin-6 induction by Helicobacter pylori in human macrophages is dependent on phagocytosis. Helicobacter. 2006; 11(3): 196-207[DOI][PubMed]
  • 33. Gobert AP, Bambou JC, Werts C, Balloy V, Chignard M, Moran AP, et al. Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J Biol Chem. 2004; 279(1): 245-50[DOI][PubMed]
  • 34. Harris PR, Ernst PB, Kawabata S, Kiyono H, Graham MF, Smith PD. Recombinant Helicobacter pylori urease activates primary mucosal macrophages. J Infect Dis. 1998; 178(5): 1516-20[PubMed]
  • 35. Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med. 1988; 109(1): 11-7[PubMed]
  • 36. Negrini R, Savio A, Appelmelk BJ. Autoantibodies to gastric mucosa in Helicobacter pylori infection. Helicobacter. 1997; 2 Suppl 1-6[PubMed]
  • 37. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009; 27: 485-517[DOI][PubMed]
  • 38. Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 2010; 40(7): 1830-5[DOI][PubMed]
  • 39. Miyara M, Gorochov G, Ehrenstein M, Musset L, Sakaguchi S, Amoura Z. Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev. 2011; 10(12): 744-55[DOI][PubMed]
  • 40. Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, et al. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology. 2010; 138(3): 1046-54[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments